Marsico Capital Management’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
AIM
NAMA
Marsico Capital Management's EXAS Position: Q3 2022 in Review
Marsico Capital Management sold out of Exact Sciences (EXAS) in Q3 2022, closing a stake of 75,476 shares — an estimated $2.97M sold.
Marsico Capital Management first reported a position in EXAS in Q1 2018 and held it in 18 quarters. The position peaked at $7.32M in Q2 2021. 480 funds tracked by Wall St. Rank hold EXAS as of Q3 2022.
- Marsico Capital Management reported no remaining Exact Sciences position as of Q3 2022 after selling out during the quarter.
- Marsico Capital Management sold 75,476 Exact Sciences shares in Q3 2022, an estimated $2.97M.
- Marsico Capital Management first reported a position in Exact Sciences in Q1 2018 and held it in 18 quarters.
- Marsico Capital Management's Exact Sciences position peaked at $7.32M in Q2 2021.
- 480 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2022.
Based on Marsico Capital Management's 13F filing for Q3 2022, filed 10 Nov 2022.